Chemical Component Summary

Name5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine
Identifiers5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
FormulaC18 H21 F3 N6 O2
Molecular Weight410.394
TypeNON-POLYMER
Isomeric SMILESc1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
InChIInChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)
InChIKeyCWHUFRVAEUJCEF-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count50
Chiral Atom Count0
Bond Count53
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB11666 
NameBuparlisib
Groups investigational
DescriptionBuparlisib has been used in trials studying the treatment and basic science of Lymphoma, Metastases, Lung Cancer, Solid Tumors, and Breast Cancer, among others.
Synonyms
  • Buparlisib hydrochloride
  • Buparlisibum
  • Buparlisib
Categories
  • Amines
  • Oxazines
  • Phosphatidylinositol 3-Kinases, antagonists & inhibitors
  • Pyridines
CAS number944396-07-0

Related Resource References

Resource NameReference
Pharos CHEMBL2017974
PubChem 16654980
ChEMBL CHEMBL2017974
ChEBI CHEBI:71954